Skip to main content
. 2022 Apr 2;14(4):e23750. doi: 10.7759/cureus.23750

Table 5. Comparison of comorbidities between the groups in study population.

S.N. Comorbidities Group S (n=110) Group C (n=110) Total (N=220)
No. % No. % No. %
1. No comorbidities 71 64.5 66 60 137 62.3
2. Comorbidities 39 35.5 44 40 83 37.7
χ2=0.484 (df=1); p=0.487